Chemotherapy Hospitals Immunity 
Pharmaceutical Technology
JANUARY 17, 2023
Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The post Hospital Universitario and Josep Carreras develop cell therapy for leukaemia appeared first on Pharmaceutical Technology.
pharmaphorum
SEPTEMBER 11, 2022
With the results in hand, the developers of the therapy – from the Netherlands Cancer Institute and Norway’s National Center for Cancer Immune Therapy – say they now intend to file for regulatory approvals in Europe before the end of the year, without a commercial partner “to try to ensure that it remains affordable.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 26, 2023
More specifically, CAR-T cell therapy engineers a patient’s own immune cells (T-cells) to detect, target, and destroy cancer cells. After initial chemotherapy, up to 45% of patients with DLBCL will require a second line treatment, which often involves high-dose chemotherapy and a stem cell transplant.
RX Note
AUGUST 4, 2023
What can I expect once I entered hospital provisional registered pharmacist training? In most hospitals, you first introduction to your workplace is through an induction period during which you are shown many different areas and meet many new people. What to do if I did not know the answer to questions from patients or doctors?
pharmaphorum
AUGUST 31, 2022
In May, a Phase 2 study started, comparing Kaiku’s electronic patient-reported outcome (ePRO) approach to evaluating immune-related adverse events to the standard model of care in cancer patients treated with checkpoint inhibitor drugs, with results due towards the end of 2023 or in early 2024.
Pharmaceutical Business Review
MARCH 6, 2024
A monoclonal antibody, Dostarlimab works by aiding the immune system in combating cancer. Administered as a 30-minute intravenous infusion in hospitals, it has shown in clinical trials to enhance life expectancy and prolong the period before the cancer’s progression when given along with platinum-based chemotherapy.
pharmaphorum
JUNE 8, 2021
“If we work closely with government stakeholders and possibly collaborate on developing innovative access schemes for rare diseases, cancers, immune and inflammatory disorders, we can encourage greater participation by established biopharmas and stimulate the growth of entrepreneurial local companies in the region.”. million in 2030.
Expert insights. Personalized for you.
110 
Let's personalize your content